Please assess the completion status of the following clinical trial:

Trial Title: Patients Response to Early Switch To Oral:Osteomyelitis Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Only adult patients will be invited to participate in this trial (age ≥ 18 years). A patient will be considered a candidate to participate in this trial if the following two inclusion criteria are present:~  1. Isolation of an organism from bone culture that is susceptible to intravenous and oral antibiotics.~ 2. Plus at least one of the following:~     * Evidence of local inflammatory response, manifested as local pain, edema, erythema, warmth, or drainage.~    * Evidence of systemic inflammatory response, manifested as fever, elevated C---reactive protein (CRP) level, erythrocyte sedimentation rate (ESR), or white blood cell count.~* \*Osteomyelitis---compatible findings on plain radiograph, computed tomography, bone scan, magnetic resonance imaging, or positron emission tomography.~  * Pathology report indicative of osteomyelitis.~Exclusion Criteria:~* A patient will not be considered as a candidate to participate in this study if the study team expects the subject to be non---compliant with the study follow---up clinic visit.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Intravenous antibiotics (Type: ACTIVE_COMPARATOR): Intravenous antibiotics for the full duration of therapy
- oral antibiotics (Type: ACTIVE_COMPARATOR): intravenous antibiotic therapy plus early switch to oral antibiotic therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).